Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer

Cancer is a very heterogeneous disease, and biological variability adds a further level of complexity, thus limiting the ability to identify new genes involved in cancer development. Oncogenes whose expression levels control cell aggressiveness are very useful for developing cellular models that per...

Descripción completa

Detalles Bibliográficos
Autores principales: Maurizio, Elisa, Wiśniewski, Jacek R., Ciani, Yari, Amato, Angela, Arnoldo, Laura, Penzo, Carlotta, Pegoraro, Silvia, Giancotti, Vincenzo, Zambelli, Alberto, Piazza, Silvano, Manfioletti, Guidalberto, Sgarra, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762532/
https://www.ncbi.nlm.nih.gov/pubmed/26527623
http://dx.doi.org/10.1074/mcp.M115.050401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4762532/
https://www.ncbi.nlm.nih.gov/pubmed/26527623
http://dx.doi.org/10.1074/mcp.M115.050401

Ejemplares similares